|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online October 26, 2004 as doi:10.1096/fj.04-2695fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






* Laboratory of Molecular Biology and Stem Cell Engineering, National Institute of Biostructures and Biosystems, University of Bologna, Bologna, Italy;
Department of Biomedical Sciences, University of Sassari, Sassari, Italy; and
ICEmB at Department of Physics, University of Bologna, Bologna, Italy
1Correspondence: Malpighi Hospital, Institute of Cardiology, Pavilion 21, Bologna, Italy 40138. E-mail: cvent{at}libero.it
SPECIFIC AIMS
Although magnetic fields (MF) have been shown to affect cell proliferation and growth factor expression in cultured cells, compelling evidence that MF may trigger a coordinate program of cell differentiation is still lacking. Here we explored whether MF may be able to prime the expression of genes encoding for tissue-restricted transcription factors in pluripotent mouse embryonic stem (ES) cells and whether, in the affirmative, ES cell exposure to MF may ultimately ensue into targeted cell lineage specification.
PRINCIPAL FINDINGS
1. ES cell exposure to extremely low-frequency MF triggers GATA-4 and Nkx-2.5 gene expression
A sinusoidal MF (50 Hz, 0.8 mT rms) was applied to GTR1 cells, a derivative of pluripotent mouse R1 ES cells bearing the puromycin resistance gene driven by the cardiomyocyte-specific
-myosin heavy chain promoter. Treatment was performed continuously after removal of leukemia inhibitory factor (LIF) until time of collection of embryoid bodies or ES-derived cardiomyocytes (3 or 10 days from LIF withdrawal, respectively). In both groups of cells, MF remarkably increased the expression of GATA-4 and Nkx-2.5 mRNA, encoding for a zinc finger-containing transcription factor and a homeodomain that are essential for cardiogenesis in various animal species, including humans (Fig. 1
).
|
2. MF induces the activation of an endorphinergic system
MF enhanced prodynorphin mRNA expression and levels of dynorphin B, a bioactive end product of the gene acting as a natural agonist of kappa opioid receptors, in both EBs and ES-derived cardiomyocytes, as well as in their incubation media (Fig. 1)
. Prodynorphin gene and dynorphin B expression has been found to play a major role in ES cell cardiogenesis priming GATA-4 and Nkx-2.5 transcription through the activation of protein kinase C signaling and nuclear opioid receptors.
3. MF acts at the transcriptional level
Nuclear run-off transcriptional analysis revealed that the transcription rate of the GATA-4 gene was greatly enhanced in nuclei that had been isolated from EBs or ES-derived cardiomyocytes obtained from MF-exposed cells compared with nuclei from unexposed cells (Fig. 1)
.
4. MF increases the yield of ES-derived cardiomyocytes
Activation of a program of cardiac lineage-restricted genes was associated with an increase in the expression of the cardiac specific transcripts
-myosin heavy chain (MHC) and myosin light chain-2V (Fig. 2
). MHC expression in cardiomyocytes from MF-exposed cells was further confirmed in immunofluorescence studies (Fig. 2)
. Exposure of GTR1 ES cells to MF after LIF removal and throughout 4 days of puromycin selection consistently increased the yield of ES-derived cardiomyocytes (number of beating colonies reached 180.38±33.0% of the control value estimated in cardiomyocytes selected from unexposed cells; mean ±SE of 4 separate experiments).
|
5. Effect of MF on the expression of genes promoting non-myocardial lineages
It is noteworthy that expression of MyoD, a gene involved in skeletal myogenesis, was not affected in EBs derived from MF-exposed cells. EBs from exposed cells exhibited a slight increase in expression of neurogenin1, a neuronal specification gene.
CONCLUSIONS AND SIGNIFICANCE
MF have been shown to elicit behavioral changes in intact organisms and cell proliferation in vitro. Our data showing the ability of MF to prime a gene expression pattern of cardiogenesis may profoundly affect our understanding of the biological consequences of MF exposure at cellular level. Failure of MF to affect the transcription of a gene promoting skeletal muscle determination and the faint effect on neuronal specification seem to exclude a generalized activation of repressed genes and suggests that coupling of MF with GATA-4, Nkx-2.5 and prodynorphin gene expression may represent a mechanism pertaining to ES cell cardiogenesis.
Stem cells were proposed recently as a renewable source of donor cells for the rescue of damaged tissues. However, such a rescuing potential is limited by the fact that differentiating cells withdraw early from the cell cycle, and development of strategies affording high throughput of targeted lineages from pluripotent cells would have obvious biomedical implications. Overexpression of tissue-specific genes by vector-mediated gene transfer is a cumbersome approach that may perturb normal homeostasis in stem cells and recipient tissues and is not readily envisionable in humans. The current finding that MF can elicit a remarkable increase in the yield of ES-derived cardiomyocytes provides evidence for the potential use of magnetic fields in modifying the gene program of cardiac differentiation in ES cells without the aid of gene transfer technologies. This may have further implications in the development of strategies modulating stem cell differentiation, an important assignment for stem cell biology and cellular engineering.
Studies are under way to shed more light on molecular events underlying the differentiating response primed by MF in ES cells.
|
FOOTNOTES
To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.04-2695fje;
This article has been cited by other articles:
![]() |
S. LEV, I. KEHAT, and L. GEPSTEIN Differentiation Pathways in Human Embryonic Stem Cell-Derived Cardiomyocytes Ann. N.Y. Acad. Sci., June 1, 2005; 1047(1): 50 - 65. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |